ArticleNeuroradiology2025
Stent-assisted repeated aspiration thrombectomy in cerebral venous sinus thrombosis: initial experience with a novel technique.
Article in Neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeThis study aimed to evaluate the efficiency and safety of stent-assisted repeated aspiration thrombectomy (SARA) in treating cerebral venous sinus thrombosis (CVST). MATERIALS AND
methodsWe conducted a retrospective analysis of 13 CVST patients treated with the SARA technique between May 2020 and May 2024. Outcomes assessed included technical recanalization rates, procedure-related complications, symptomatic intracranial hemorrhage and functional outcomes at 90 days.
resultsThe mean procedure time was 159.9 ± 22.4 (95%CI, 146.3-173.4) minutes. According to TO-ACT criteria, per-patient primary angiographic outcomes were: complete recanalization in 8/13 patients (61.5%, 95%CI 30.9%-92.1%), partial recanalization in 5/13 patients (38.5%, 95%CI 7.9%-69.1%), and none in 0/13 patients (0%). Successful recanalization rates were as follows: superior sagittal sinus (72.7%, 8/11), torcular herophili (75.0%, 6/8), lateral sinus (81.8%, 9/11), internal jugular veins (100%, 4/4), and straight sinus (80.0%, 4/5). No procedure-related complications or symptomatic intracranial hemorrhage (sICH) were observed, and 84.6% (11/13) of patients achieved favorable clinical outcomes at 90 days.
conclusionsThe SARA technique appears to be a safe and effective endovascular treatment for CVST.
Indexed as
Identifiers
41204955What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.